Business
Currency:USD
2018/FY
Stock NameRevenueRatio
Development of its drug product candidate DM199 for the treatment of severe ischemic disease500K100.00%
Region
Currency:USD
2018/FY
Stock NameRevenueRatio
United States500K100.00%